OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 12:27:07 2024-07-03 pm EDT | ||
| 0.951 EUR | +4.05% |
|
| Current month | +21.46% | ||
| 1 month | +24.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 0.951 | +4.05% |
| 24-07-02 | 0.914 | +8.55% |
| 24-07-01 | 0.842 | +7.54% |
| 24-06-28 | 0.783 | -4.04% |
| 24-06-27 | 0.816 | +12.55% |
Real-time BOERSE MUENCHEN
Last update July 03, 2024 at 12:27 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG64JB |
| ISIN | DE000GG64JB4 |
| Date issued | 2024-04-12 |
| Strike | 50.36 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.952 € |
|---|---|
| Lowest since issue | 0.104 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.06
USD
Average target price
53.19
USD
Spread / Average Target
+32.79%
- Stock Market
- Certificates
- Certificat
